期刊文献+

不同剂量野百合碱诱导大鼠肺动脉高压模型的实验研究 被引量:8

Experimental Study on Different doses of Monocrotaline-induced Pulmonary Hypertension in Rats
下载PDF
导出
摘要 目的观察不同剂量的野百合碱诱导大鼠肺动脉高压模型的建立,探索合适的野百合碱造模剂量。方法将60只雄性SD大鼠随机分成4组,正常对照组、野百合碱低剂量组、野百合碱中剂量组和野百合碱高剂量组,一次性给予颈背部皮下注射不同剂量野百合碱诱导建立肺动脉高压大鼠模型。4周后,测量各组大鼠肺动脉压力、心输出量、肺血管阻力以及右心室肥厚程度。结果野百合碱高剂量组大鼠死亡率、肺动脉压力、右心室室壁厚度高于中剂量组、低剂量组和正常对照组(P<0.001),心输出量低于中剂量组、低剂量组和正常对照组(P<0.001);高剂量组肺动脉压力、肺血管阻力高于中剂量组、低剂量组(P<0.001)。结论中剂量组野百合碱诱导的大鼠肺动脉高压模型更为接近大鼠肺动脉模型的理想数值。 Objective To investigate the different doses of monocrotaline induced pulmonary hypertension and explore situable monocrotaline dose to model pulmonary hypertension.Methods Sixty male Sprague Dawley rats were randomly divided into four groups, normal control group, low dose group, middle close group and high dose group, rats were given subcutaneous injection of appropriate doses of monocrotaline disposably in order to induce the formation of pulmonary hypertension.After our weeks, the pulmonary arterial pressure, cardiac output, pulmonary vascular resistance and right ventricle hypertrophy were measured.Results The mortality rate in high dose group was higher than that in low - dose group and control group.Mean pulmonary arterial pressure and right ventricular wall thickness in high doses group was higher than that in moderate dose group, low dose group, and control group( P 〈0.001).Cardiac output in high doses group was lower than that in moderate dose group, low dose group, and control group( P 〈0.001).Conclusion The moderate dose monocrotaline induced pulmonary hypertension is closer to the ideal value model.
出处 《中西医结合心脑血管病杂志》 2015年第10期1172-1175,共4页 Chinese Journal of Integrative Medicine on Cardio-Cerebrovascular Disease
基金 国家自然科学基金资助项目(No.81273948)
关键词 肺动脉高压 野百合碱 心输出量 肺血管阻力 右心室肥厚 pulmonary arterial hypertension monocrotaline cardiac output right ventricle hypertrophy
  • 相关文献

参考文献12

  • 1Matsuda Y,Hoshikawa Y,Ameshima S, et aI.Effects of peroxi some proliferator activated receptor gamma ligands on monocro taline induced pulmonary hypertension in rats[J].Nibon Kokyuki Zasshi,2005(5) :283 -288.
  • 2Tan Albada ME, Schoemaker RG, Kemna MS, et al .The role of increased pulmonary blood flow in pulmonary arterial hyperten sion[J].Eur Respir J,2005(3) :487- 493.
  • 3袁平,吴文汇,刘岽,张锐,荆志成.改良心导管测定大鼠肺血管阻力的方法[J].中华心血管病杂志,2011,39(10):901-904. 被引量:14
  • 4Hesel MH,Steendijk P, den Adel B, et aI.Characterization of right ventricular function after monocrotaline induced pulmonaryhypertension in the intact rat[J].Am J Physiol Heart Cric Physi- oh 2006,209 : H2424 - H2430.
  • 5Kay JM, Harris P, Heath D.Pulmonary hypertension produced in rats by ingestion of Crotalaria spectabilis seeds[J].Thorax, 1967 (22) : 176 - 179.
  • 6Jasmin JF, Lucas M, Cernacek P, et al .Effective of a nonselec- tive ETA/B and a selective ETA antagonist in rats with mono - crotaline - induced pulmonary hypertension [ J]. Circulation, 2001,103:314 - 318.
  • 7Obata H,Sakai Y,Ohnishi S, et al .Single injection of the a sus- tained- release prostacyclin analog improves pulmonary hyper- tension in rats[J].Am J Respir Crit Care Med, 2008, 177: 195- 201.
  • 8Taraseviciene - Stewart L, Kasahara Y, Alger L, et al .Inhibition of the VEGF receptor 2 combined with chronic hypoxia causes cell death - dependent pulmonary endothelial cell proliferationand severe pulmonary hypertension[J] .FASEB J, 2001,15 : 427 - 438.
  • 9Herget J, Palecek F.Pulmonary arterial blood pressure in closed chest rats.Changes after catecholamines, histamine and seroto- nin[J].Arch Int Pharmacodyn Ther, 1972,196,107 - 117.
  • 10Ishikawa M, Sato N, Asai K, et al .Effects a pure alpha/beta - ad- renergic receptor blocker on monocrotaline - induced pulmonary hypertension with right ventricular hypertrophy in rats[J].Circ J, 2009,73: 2337 - 2341.

二级参考文献19

  • 1孙菊光,奚肇庆,姜静,朱萱萱,洪建军,蒋萌,邹建东,徐艳,甘咏梅.复方薤白胶囊对野百合碱诱导肺动脉高压大鼠ET、TNFα含量的影响[J].东南大学学报(医学版),2006,25(5):337-340. 被引量:17
  • 2孙波 刘文利.右心导管测定大鼠肺动脉压的实验方法[J].中国医学科学院学报,1984,6:465-465.
  • 3Rubin LJ.Primary pulmonary hypertension.N Engl J Med,1997,336:111-117.
  • 4Herget J,Palecek F.Pulmonary arterial blood pressure in closed chest rats.Changes after catecholamines,histamine and serotonin.Arch Int Pharmacodyn Ther,1972,198:107-117.
  • 5Herget J,Novotna J,Bibova J,et al.Metalloproteinase inhibition by Batimastat attenuates pulmonary hypertension in chronically hypoxic rats.Am J Physiol Lung Cell Mol Physiol,2003,285:L199-L208.
  • 6Sawamura F,Kato M,Fujita K,et al.Tadalafil,a long-acting inhibitor of PDE5,improves pulmonary hemodynamics and survival rate of monocrotaline-induced pulmonary artery hypertension in rats.J Pharmacol Sci,2009,111:235-243.
  • 7Sauvageau S,Thorin E,Villeneuve L,et al.Endothelin-3-dependent pulmonary vasoconstriction in monocrotaline-induced pulmonary arterial hypertension.Peptides,2008,29:2039-2045.
  • 8Daicho T,Yagi T,Abe Y,et al.Possible involvement of mitochondrial energy-producing ability in the development of right ventricular failure in monocrotaline-induced pulmonary hypertensive rats.J Pharmacol Sci,2009,111:33-43.
  • 9Hessel MH,Steendijk P,den Adel B,et al.Characterization of right ventricular function after monocrotaline-induced pulmonary hypertension in the intact rat.Am J Physiol Heart Circ Physiol,2006,291:H24.24-H2430.
  • 10Ishikawa M,Sato N,Asai K,et al.Effects of a pure alpha/betaadrenergic receptor blocker on monocrotaline-induced pulmonary arterial hypertension with right ventricular hypertrophy in rats.Circ J,2009,73:2337-2341.

共引文献32

同被引文献50

引证文献8

二级引证文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部